Evidence map›Paper›PMID 40801457›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Enantioselective Alkoxycarbonyl-Lactonization of Alkenes via the Merger of Photoredox and Copper Catalysis.

Yuping Xiong, Zhipeng Zong, Wenlin Xie, Jian-Qiang Chen, Xiaoyu Zhou, Jie Wu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuping XiongSchool of Pharmaceutical and Chemical Engineering & Institute for Advanced Studies, Taizhou University, Taizhou, 318000, China.
Zhipeng ZongSchool of Pharmaceutical and Chemical Engineering & Institute for Advanced Studies, Taizhou University, Taizhou, 318000, China.
Wenlin XieSchool of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, 411201, China.
Jian-Qiang ChenSchool of Pharmaceutical and Chemical Engineering & Institute for Advanced Studies, Taizhou University, Taizhou, 318000, China.ORCID https://orcid.org/0000-0001-8144-9069
Xiaoyu ZhouSchool of Pharmaceutical and Chemical Engineering & Institute for Advanced Studies, Taizhou University, Taizhou, 318000, China.
Jie WuSchool of Pharmaceutical and Chemical Engineering & Institute for Advanced Studies, Taizhou University, Taizhou, 318000, China.ORCID https://orcid.org/0000-0002-0967-6360

Funding

National Natural Science Foundation of China 22201201National Natural Science Foundation of China 22371201Natural Science Foundation of Zhejiang Province LY23B020001Natural Science Foundation of Zhejiang Province LZ23B020001Zhejiang Provincial Ten Thousand Talent Program 2023R5244
6 · The paper itself

Abstract

The synthesis of ester derivatives represents one of the most significant and fundamental tasks in modern organic chemistry, and numerous methods have been developed in both academic and industrial contexts. Among these, alkoxycarbonyl radical-mediated functionalization strategies have emerged as a highly efficient and versatile tool for the synthesis of these compounds. Despite the significant advancements in recent years, the radical-induced enantioselective alkoxycarbonylation reaction remains largely unexplored. Herein, a highly enantioselective alkoxycarbonyl-lactonization of alkenes is reported through a photoredox/copper dual-catalyzed alkoxycarbonyl radical addition/cyclization reaction. With this approach, a diverse array of ester-substituted chiral γ-butyrolactones bearing a quaternary stereocenter can be readily obtained in high yields and with excellent enantioselectivities under mild reaction conditions. This versatile method shows good substrate tolerance for primary, secondary, and tertiary alcohol derivatives while maintaining exceptional stereochemical control.

Indexed as

chiral γ‐butyrolactonesenantioselective alkoxycarbonylationlactonizationphotocatalysisradical

Identifiers

PMID40801457
PMCPMC12622489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.